# EDGAR Filing Document

**Accession Number:** 0001763950
**File Stem:** 9999999995-26-002072
**Filing Date:** 2026-6
**Character Count:** 1409
**Document Hash:** 26c2333e5b090955d9a285e062724b2b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**9999999995-26-002072.hdr.sgml**: 20260622

**ACCESSION NUMBER**: 9999999995-26-002072

**CONFORMED SUBMISSION TYPE**: EFFECT

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260618

**DATE AS OF CHANGE**: 20260622

**EFFECTIVENESS DATE**: 20260618

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Lantern Pharma Inc.
- **CENTRAL INDEX KEY:** 0001763950
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 463973463
- **STATE OF INCORPORATION:** TX
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** EFFECT
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-296752
- **FILM NUMBER:** 261104730

**BUSINESS ADDRESS:**
- **STREET 1:** 1920 MCKINNEY AVENUE
- **STREET 2:** 7TH FLOOR
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75201
- **BUSINESS PHONE:** 972-277-1136

**MAIL ADDRESS:**
- **STREET 1:** 1920 MCKINNEY AVENUE
- **STREET 2:** 7TH FLOOR
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75201

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Lantern Pharma
- **DATE OF NAME CHANGE:** 20190108

### UNITED STATES
### SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## Notice of Effectiveness

**Date:** June 18, 2026

**Time:** 16:30:00

**Form Type:** S-1

---

**CIK:** 0001763950

**Company Name:** Lantern Pharma Inc.

**File Number:** 333-296752